ATE108207T1 - Polypeptide und dafür kodierende dna. - Google Patents

Polypeptide und dafür kodierende dna.

Info

Publication number: ATE108207T1
Authority: AT; Austria
Prior art keywords: polypeptides; amino acid; acid residue; dna coding; coding therefor
Prior art date: 1988-02-03

Application number

AT89301007T

Other languages

English (en)

Inventor

Michiko Yamayoshi

Hitoshi Kawashima

Junichi Yamagishi

Hirotada Kotani

Ryuji Furuta

Toshikazu Fukui

Original Assignee

Dainippon Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-03

Filing date

1989-02-02

Publication date

1994-07-15

1989-02-02 Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co

1994-07-15 Application granted granted Critical

1994-07-15 Publication of ATE108207T1 publication Critical patent/ATE108207T1/de

Links

229920001184 polypeptide Polymers 0.000 title abstract 4
102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
125000000539 amino acid group Chemical group 0.000 abstract 3
102000000589 Interleukin-1 Human genes 0.000 abstract 2
108010002352 Interleukin-1 Proteins 0.000 abstract 2
125000003275 alpha amino acid group Chemical class 0.000 abstract 2
230000004913 activation Effects 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
229960002986 dinoprostone Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
210000004698 lymphocyte Anatomy 0.000 abstract 1
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Microbiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT89301007T 1988-02-03 1989-02-02 Polypeptide und dafür kodierende dna. ATE108207T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP63024613A JP2698976B2 (ja)	1988-02-03	1988-02-03	新規ポリペプチド及びそれをコードするｄｎａ

Publications (1)

Publication Number	Publication Date
ATE108207T1 true ATE108207T1 (de)	1994-07-15

Family

ID=12142999

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89301007T ATE108207T1 (de)	1988-02-03	1989-02-02	Polypeptide und dafür kodierende dna.

Country Status (6)

Country	Link
EP (1)	EP0327360B1 (de)
JP (1)	JP2698976B2 (de)
KR (1)	KR960016705B1 (de)
AT (1)	ATE108207T1 (de)
DE (1)	DE68916559T2 (de)
ES (1)	ES2059717T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2667601A1 (fr) *	1990-10-05	1992-04-10	Rhone Poulenc Sante	Polypeptides derives de l'interleukine-1 beta, procede de preparation et utilisation, notamment dans le cadre des pathologies osteoarticulaires.
US7176179B1 (en)	1997-05-30	2007-02-13	The Regents Of The University Of California	Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en)	1998-06-24	2003-08-14	Farese Robert V.	Methods and compositions for modulating carbohydrate metabolism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3587605T2 (de) *	1984-12-25	1994-03-17	Dainippon Pharmaceutical Co	Interleukin-1 und dessen Derivat.
EP0200986B2 (de) *	1985-04-25	1998-03-11	F. Hoffmann-La Roche Ag	Rekombinantes Humaninterleukin-1
JP2591615B2 (ja) *	1986-03-14	1997-03-19	大塚製薬株式会社	インターロイキン−１β誘導体及び医薬
US5008374A (en) *	1986-03-14	1991-04-16	Otsuka Pharmaceutical Co., Ltd.	IL-1α derivatives and drugs
US5017692A (en) *	1986-09-04	1991-05-21	Schering Corporation	Truncated human interleukin-a alpha

1988
- 1988-02-03 JP JP63024613A patent/JP2698976B2/ja not_active Expired - Lifetime
1989
- 1989-02-02 ES ES89301007T patent/ES2059717T3/es not_active Expired - Lifetime
- 1989-02-02 AT AT89301007T patent/ATE108207T1/de not_active IP Right Cessation
- 1989-02-02 DE DE68916559T patent/DE68916559T2/de not_active Expired - Fee Related
- 1989-02-02 EP EP89301007A patent/EP0327360B1/de not_active Expired - Lifetime
- 1989-02-02 KR KR1019890001221A patent/KR960016705B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2059717T3 (es)	1994-11-16
DE68916559T2 (de)	1994-11-03
EP0327360B1 (de)	1994-07-06
KR890013177A (ko)	1989-09-21
DE68916559D1 (de)	1994-08-11
JP2698976B2 (ja)	1998-01-19
EP0327360A2 (de)	1989-08-09
JPH01199998A (ja)	1989-08-11
KR960016705B1 (ko)	1996-12-20
EP0327360A3 (en)	1990-05-02

Legal Events

Date	Code	Title	Description
1995-02-15	UEP	Publication of translation of european patent specification
1998-11-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
LV10507A (lv)	1995-02-20	Vektors sunas eritroproteins farmaceitiska kompozicija
GR3021198T3 (en)	1996-12-31	Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
ATE182901T1 (de)	1999-08-15	Für androgen-rezeptor-protein kodierende dna
ATE417057T1 (de)	2008-12-15	Mutierte formen des fas liganden und deren verwendung
IT1153265B (it)	1987-01-14	Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi
IL81018A (en)	1992-03-29	Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
DE69939330D1 (de)	2008-09-25	Wachstumsfaktor-homologe zvegf-3
ATE121776T1 (de)	1995-05-15	Expression des biologisch aktiven faktors xiii.
ATE85809T1 (de)	1993-03-15	Herstellung des menschlichen von-willebrandfaktors durch rekombinante dns.
DE3881023D1 (de)	1993-06-17	Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0336779A3 (de)	1991-08-21	Durch kovalenten Ersatz von Wasserstoffbrücken stabilisierte Polypeptide
ATE142256T1 (de)	1996-09-15	Polypeptid und dessen herstellung
HUT50195A (en)	1989-12-28	New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
ATE108207T1 (de)	1994-07-15	Polypeptide und dafür kodierende dna.
SE8801723D0 (sv)	1988-05-06	Fibronectin binding protein as well as its preparation
DE58909261D1 (de)	1995-06-29	Ancrod-proteine, ihre herstellung und verwendung.
FI895183A0 (fi)	1989-11-01	Foerfarande foer selektiv spjaelkning av fusionsproteiner.
ATE110112T1 (de)	1994-09-15	Verfahren und systeme zur herstellung von hiv- antigenen.